Investigation of the Effect of Abdominal Massage Applied to Palliative Care Patients on Constipation and Quality of Life
NCT ID: NCT05742672
Last Updated: 2023-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2022-12-01
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Abdominal Massage on Palliative Care Patients
NCT05580679
The Effect of Abdominal Massage Applied to Patients by Caregivers in Palliative Care Clinics on Gastrointestinal Symptoms
NCT07244302
Effect of Abdominal Massage on Constipation After Cardiac Surgery
NCT06596421
Prevention of Constipation in Cancer Patients
NCT07007468
The Effects of Abdominal Massage on Functional (Primary) Chronic Constipation
NCT03764995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the first phase of the research, answers to the following questions will be sought.
What is the severity of constipation in palliative care patients?
-Performing daily living activities of palliative care patients How is the dependency independence situation?
Hypotheses of the Research:
H1: The application of abdominal massage to palliative care patients has an effect on constipation.
H1: The application of abdominal massage to palliative care patients has a positive effect on the quality of life.
The independent variable of the study was abdominal massage application, and the dependent variables were constipation and quality of life levels of palliative care patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Massage
In the experimental group, twice a day, in the morning and evening, and 30 minutes after the meal, for 15 minutes. Effusion, petrissage and vibration massage movements will be applied by the researcher for a certain period of time in accordance with the procedure (Abdominal Massage Application Directive). The application will continue for 7 days.
ABDOMINAL MASSAGE APPLICATION
* Experiment group twice a day in the morning and evening and 30 minutes after the feeding meal, for 15 minutes. For a period of time, effusion, petrissage, vibration massage movements will be applied by the researcher in accordance with the procedure (Abdominal Massage Application Directive). The application will continue for 7 days.- On the 3rd day (short term), 5th day (mid term) and 7th day (long term) to the massaged experimental group, the Constipation Severity Scale (CQS) and the Constipation Quality of Life Scale (QQQL) will be administered to determine the effect.
* Day 7 Rome Ш Constipation Diagnostic Criteria (Annex: 2) will be applied again and the patient's constipation status will be evaluated for the last time.
* Routine treatment and care practices in the clinic will continue.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ABDOMINAL MASSAGE APPLICATION
* Experiment group twice a day in the morning and evening and 30 minutes after the feeding meal, for 15 minutes. For a period of time, effusion, petrissage, vibration massage movements will be applied by the researcher in accordance with the procedure (Abdominal Massage Application Directive). The application will continue for 7 days.- On the 3rd day (short term), 5th day (mid term) and 7th day (long term) to the massaged experimental group, the Constipation Severity Scale (CQS) and the Constipation Quality of Life Scale (QQQL) will be administered to determine the effect.
* Day 7 Rome Ш Constipation Diagnostic Criteria (Annex: 2) will be applied again and the patient's constipation status will be evaluated for the last time.
* Routine treatment and care practices in the clinic will continue.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years and over,
* A first-degree relative or volunteer to participate in the research approved to participate in the research by
* Having at least 2 or more of the Rome III constipation diagnostic criteria,
* Constipation Severity Scale score is 25 and above,
* No intestinal obstruction
* No radiotherapy or surgery was applied to the abdominal region until six weeks ago,
* Does not have diarrhea,
* Patients who do not have abdominal massage application restrictions.
Exclusion Criteria
* under the age of 18,
* Patients who do not receive inpatient treatment and care in the palliative care service.
* Those who do not volunteer to participate in the research or who are not approved to participate in the research by their first-degree relatives,
* Below 2 of the Rome III constipation diagnostic criteria
* Constipation Severity Scale score below 25 points
* Intestinal obstruction
* Radiotherapy or surgery was applied to the abdominal region up to six weeks ago,
* Having diarrhea
* Patients with abdominal massage application restrictions will be formed.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eskisehir Osmangazi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sevil PAMUK CEBECİ
Asst.Prof.Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sevil PAMUK CEBECİ
Eskişehir, Eskişehir, Turkey (Türkiye)
Eskişehir Şehir Hastanesi
Eskişehir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.